In this work, we used the two-stage residual inclusion individual frailty (2SRI-F) algorithm. 1 We conducted two comparisons (PTA vs. atherectomy and stent vs. atherectomy) through two different IVs. The algorithm is as follows:
are K measured covariates and is the total number of relevant surgeries performed in the past 12-months.
3. We saved the residuals from the previous model: .
[Second Stage]
We performed a proportional hazards Cox regression model with individual frailties including the covariates in [1] and the residuals, Rj.
We performed the 2-SRI-F procedure twice, once for the PTA vs. atherectomy comparison using IV1, and again for the stent vs. atherectomy comparison using IV2.
R code
1. Computing the IV for comparing treatments T1 and T2 [N is the sample size]
2. First Stage. [We adjusted data.t1 to just include two considered therapies and tr2 is defined appropriately]. Notice that the sample size, n1, just considers the two treatments.
S1= lm(trt2 ~ iv1 + race + age + … + htn +nprev1, data=data.t1) data.t1$PRE= as.numeric(predict(S1,data.t1)) data.t1$RES= data.t1$trt2 -data.t1$PRE
Second Stage. [survival package is required]
tsA<-coxph( Surv(timeAny,eventAny)~ trt2 + race + age + … + RES + nprev1 + frailty(1:n1,dis="gauss"), data=data.t1) Data S2.
Instrumental Variable Assumption Assessment
The generalizability and validity of our IV findings depends on the strength with which we can make three key assumptions about our instrument. These assumptions are that our instrument: 1) has a causal effect on the exposure 2) only affects the outcome through the exposure 3) does not share common causes with the outcome. If these assumptions are held, then the effect we observed can be causal. 2 We found that our instruments were strongly associated with our exposure, treatment type, as evidenced by the large F-statistic values and increasing use of atherectomy for patients who receive treatment at centers with a high proportion of atherectomy procedures. The other IV assumptions cannot be verified from the data; hence, we relied on the expert knowledge of vascular surgery across our team to identify any potential assumption violations. Because our instrument is so strongly related to the exposure, any proposed alternative link between the instrument and outcome was ultimately related through the treatment type. We included total procedural volume as a covariate in our IV analyses to help justify the assumption that a hospital's experience with a given procedure is unrelated to patient outcomes after conditioning on observed covariates. Conditioning on total volume stops the presence of a general surgical volume learning effect from violating the third assumption, making a procedure specific learning effect the only threat to the validity of the IV. There is no evidence in the literature of a procedure-specific learning effect for endovascular PAD treatment and long-term outcomes. Thus, after careful consideration of each assumption, we are confident in the validity of our instrument and IV results. 
